论文信息 - PROSELICA study update: Comparison of two doses of cabazitaxel (Cbz) plus prednisone (P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with a docetaxel (D)-containing regimen. - 字舞流文

PROSELICA study update: Comparison of two doses of cabazitaxel (Cbz) plus prednisone (P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with a docetaxel (D)-containing regimen.

J. Carles | J. Bono | V. Matveev | P. Mainwaring | H. Berg | Choung-Soo Kim | I. Bodrogi | B. Alekseev | J. Shapiro | A. Font | M. Eisenberger | P. Parente | A. Hardy-Bessard | I. Latorzeff | M. Chadjaa | S. Ng | L. Mourey | R. Segal | D. Ford | Wenping Zhang